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Abstract
Background: Butter is one of the widely used fats present 
in the diet. However, there is no satisfactory study avail-
able that evaluates the effect of a high-fat diet containing 
butter as the principal fat on the development of non-alco-
holic fatty liver disease (NAFLD).
Methods: In the present study, butter was used for the 
development of steatosis in Chang liver cells in an in vitro 
study and Swiss albino mice in an in vivo study. In vitro 
steatosis was established, and butter was compared with 
oleic acid in Chang liver cells using an oil red O (ORO)-
based colorimetric assay. In the in vivo study, a butter-rich 
special diet was fed for 15  weeks to mice, who showed 
no significant change in body weight. The expression 
pattern of phosphatase and tensin homolog (PTEN) and 
miR-21 was compared by reverse transcriptase-PCR.
Results and Conclusions: Special diet-fed animals showed 
downregulated PTEN compared to normal diet-fed 
animals, while levels of miR-21 remained the same. Eleva-
tions in biochemical parameters, viz., triglycerides and 
liver function tests showed symptoms of onset of NAFLD. 
Histophathological study of livers of test animals con-
firmed mild-to-moderate degree of NAFLD.
Keywords: butter; miR-21; non-alcoholic fatty liver disease 
(NAFLD); non-alcoholic steatohepatitis (NASH); phos-
phatase and tensin homolog (PTEN); steatosis.
Introduction
In recent years, an increase in the incidence of obesity 
and diabetes mellitus (non-insulin dependent) has dra-
matically increased the incidence of non-alcoholic fatty 
liver disease (NAFLD), which results in non-alcoholic 
steatohepatitis (NASH) and which may develop further to 
hepatocellular carcinoma (HCC) [1]. Nowadays, NAFLD is 
considered as a social problem due to changes in lifestyle 
comprising increased intake of a fat-rich diet and the lack 
of exercise. As a result, more people are becoming obese 
with an increase in body mass index (BMI) and insulin 
resistance, which leads to the development of NASH [2]. 
Because of the asymptomatic behavior of the NAFLD, the 
condition remains unnoticed and without treatment for 
a long time, which leads to end-stage liver disease, i.e. 
NASH and requires liver transplantation to save patients 
[3]. Although genetic, epigenetic, and nutritional changes 
are also responsible for NAFLD, the recent increase in the 
incidence of NAFLD is mainly due to fatty acid overload 
among the general population.
To study pathogenesis and development of drugs, 
animal models, simulating the conditions of human 
disease, are always an important tool, which allow the 
investigator to study the pathological conditions of a 
disease and to identify the treatment strategy for that 
particular disease. To date, no satisfactory animal model 
is available to study NAFLD. The existing animal models 
either use genetically altered mice or mice with altered 
liver metabolism [4]. For instance, in altered liver metabo-
lism, rats fed with choline-deficient (CD) and methionine 
choline-deficient (MCD) models are two animal models 
that are widely used in studies of NAFLD. In these models, 
NAFLD is induced due to the change in liver metabo-
lism and does not involve obesity. Even in MCD-fed diet 
animals, weight loss with excess in hepatocellular injury 
is observed [4, 5], which truly differentiates it from the con-
ditions associated with NAFLD observed in humans [6], 
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while genetically altered animals do not show the same 
kind of disease progression. There were other attempts to 
create new models for studying NAFLD such as intra-gas-
tric overnutrition [7], forced feeding of saturated fat-rich 
food to foz/foz mice [8], surgical implantation of gastros-
tomy tubings [7], sucrose and fructose overfeeding [7], etc. 
However, in the ideal animal model, the animal should 
develop steatohepatitis due to the feeding pattern simu-
lating the behavior observed in humans [6], which was 
missing from the newly developed model.
Cell culture and animal models for alcoholic and non-
alcoholic fatty liver disease cannot be easily simulated in 
animals as several factors are involved in the progression 
of these diseases [9]. However, a suitable in vitro model, 
which can be performed easily and rapidly at reduced cost 
and the one that is reproducible in animals, is essential 
before in vivo experiments. Besides, such in vitro tech-
niques are useful in studying the pathogenesis involved in 
NAFLD and screening, drug candidates for hepatoprotec-
tive action against steatosis [10].
Thus, the present study was aimed to study the patho-
genesis of NAFLD by the exposure of butter, a highly used 
fat in Chang liver cells using oleic acid as a control and the 
oil red O (ORO)-based colorimetric quantification method. 
Although attempts have been made to create NAFLD 
models in rats and chickens using a fat-rich diet [11, 12], it 
will be easier during a routine investigation if such models 
are created in the most commonly used Swiss albino 
mice fed with commonly used fat, i.e. butter-rich chow. 
Thus, the present study was designed to develop a new 
animal model of NAFLD by feeding chow rich in butter to 
Swiss albino mice. Furthermore, the exposed liver cells of 
animals were analyzed for PTEN and miR-21 expression. 
As the exposure of fat containing excess of unsaturated 
fatty acids to liver cells often causes PTEN deregulation/
downregulation through mTOR/NFjB-dependent mecha-
nisms and involved in the development of NAFLD and 
other related malignancies such as NASH and HCC [13]. 
The downregulation of PTEN expression leading to 
increased invasiveness of hepatoma [14] has been particu-
larly observed in the case of liver cells when compared to 
other cells, viz., breast and prostate [1]. Thus, the molecu-
lar study has been designed to validate the developed 
model through the PTEN expression pattern.
Materials and methods
All cell culture materials and media components were procured from 
Sigma-Aldrich (USA). Chang cells were procured from National Cen-
tre for Cell Sciences (Pune, India). Butter was purchased from Amul 
(India). Rat chow was procured from VRK Nutritional Solutions 
(Pune, India). Other chemicals were of the highest grade and were 
procured from Merck (India).
In vitro studies
Oleic acid-induced steatosis: Chang liver cells were maintained in 
minimum essential medium (MEM) supplemented with 10% fetal 
bovine serum (FBS) under standard cell culture conditions (37 °C, 
5% CO2). These cells were seeded into a 96-well flat bottom microti-
ter plate at a density of 20,000 cells per well and allowed to adhere 
by incubating at 37 °C in 5% CO2. The cells were supplemented with 
MEM with 10% fetal bovine serum (FBS). When the cells reached 
80% confluence, each well was treated with increasing concentra-
tion of oleic acid solution (200 μL), viz., 0.25, 0.5, 0.75, 1.0, 1.25, 1.5, 
1.75, 2.0, 4, 8, and 12 mM for 24 h. The experiments were performed 
in quadruplet. After 24 h, the cells were examined for steatosis after 
removing the media.
Detection of steatosis: Accumulations of fatty acid within cells 
were examined using the oil red O method. Briefly, the cells were 
washed three times with doubled distilled water to remove traces 
of medium. The washed cells were fixed using 100 μL of fixative 
solution containing 4% formaldehyde in phosphate-buffered saline 
(PBS) for 10  min at 37 °C. The fixative solution was removed and 
the  cells were washed with double distilled water. The washed cells 
were stained with 50 μL of 0.2% oil red O dissolved in isopropanol 
and volume adjusted with distilled water (ORO solution). The ORO-
treated cells were incubated at 37 °C for 15 min, after which the cells 
were washed with double distilled water until the solution became 
clear. This was followed by drying at 40 °C for 30 min in a hot air 
oven. After drying, the cells were mounted with glycerin and exam-
ined under a microscope. Red oil droplets in the stained cells indi-
cate oleic acid-induced steatosis.
Butter-induced steatosis: Chang liver cells, maintained as indi-
cated previously, were seeded into 96-well flat bottom microwell 
plate at a density of 20,000 cells per well and cultured at 37 °C in 5% 
CO2 atmosphere to allow for cell adhesion. After the cells attained 
80% confluence, the cells were treated with varying concentrations 
of MEM medium containing melted butter. MEM (1  mL) containing 
100 μL of melted butter was considered as 100 dilutions. From this, 
the required MEM-butter mixtures, viz., 10 − 1, 10 − 2, to 10 − 10, were pre-
pared. The experiments were performed in quadruplet. Cells were 
examined for steatosis as described previously.
ORO-based steatosis quantification: Steatosis quantification using 
the ORO method was based on the Cui et al. [10] method. Steatosis 
was induced in Chang liver cells by oleic acid and butter. The cells 
were treated with 100 μL of iso-propanol and incubated for 10 min. 
ORO was allowed to be released from the cells by gently vibrating 
the plate. The released oil-ORO complex was transferred to another 
96-well plate, and the optical density was measured at 405 nm.
Preparation of fat-rich diet: Fat-rich diet was prepared using a rat/
mice pellet. The pellet was finely grounded and passed through the 
mesh (number 8) of 2.38 mm. Marketed butter was mixed with this fine 
powder such that the final fat concentration was around 38% w/w. 
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This mixture was made into a small clump of 20 g each. This fat-rich 
diet was stored at – 20 °C until used in the animal  studies.
In vivo studies
A study was conducted after obtaining the approval from the Institu-
tional Animal Ethics Committee (IAEC) of Kasturba Medical College 
(KMC), Manipal (No. IAEC/KMC/01/2012). Swiss albino mice (male) 
2  months of age, were acclimatized to the experimental room hav-
ing a temperature of 23 ± 2 °C, controlled humidity conditions, and 
a 12 : 12-h light and dark cycle. Animals were caged in polypropylene 
cages with a maximum of four animals in each cage. The mice were 
divided in two groups. One group was fed with standard food pel-
let, i.e. without the addition of butter; the other group was fed with 
a specially formulated diet. Both groups were provided fresh water 
ad libitum. An initial pilot study was carried out for 1  week with 
four animals to check for the palatability of the specially formulated 
diet for the mice after which the main experiment was carried out. 
Forty-eight mice were divided into two main groups. Twenty-four 
mice were provided with the standard food pellets and water (con-
trol group). The other group was fed with the formulated diet and 
water (special diet group). These main groups were further subdi-
vided into three subgroups consisting of eight animals in each sub-
group. Each subgroup had one control and one special diet group. 
The feed was weighed and added to each cage in multiples of 20 g of 
feed per animal. All the animals were weighed regularly at an inter-
val of 3–4 days. The feed remaining in the cages was also weighed to 
calculate the amount of food consumed. All data were recorded. The 
cages were changed every third day for maintenance. Animals from 
each group were sacrificed at the 35th, 70th, and 105th days. Blood 
was withdrawn retro-orbitally from the animals under light anesthe-
sia; after which, the animals were sacrificed by cervical dislocation. 
Plasma from the blood mixed with EDTA was separated and stored at 
– 20 °C until further processing. Livers removed from the sacrificed 
animals were divided into two halves. One-half was stored in 4% 
formaldehyde solution and another at – 80 °C for further processing. 
The change in the animal weight and the average amount of feed/
special diet consumed were recorded regularly.
Expression studies: RT-PCR analysis
PTEN and miR-21 expression studies using reverse transcriptase-PCR 
analysis: RNA was extracted from the excised livers (100 mg) using 
TRIzol reagent (Invitrogen, USA) and quantified by UV spectrometry 
(A260/280 method). cDNA was synthesized from isolated RNA using 
Invitrogen’s SuperScript® III First-Strand synthesis as per the manu-
facturer’s protocol. DNA was synthesized from cDNA for PTEN and 
Table 1: Primer sequences.
Primers Sequence
PTEN forward primer -GAC AGC CAT CAT CAA AGA GAT CG
PTEN reverse primer -GGT TCA TTC TCT GGA TCA GAG TCA GTG
miR-21 forward primer -GTC GGG TAG CTT ATC AGA CTG
miR-21 reverse primer -CAG ACA GCC CAT CGA CTG GTG
miR-21with respective primers using Invitrogen’s KOD hot start DNA 
polymerase as per the manufacturer’s protocol. RNA and PCR prod-
uct were run on 1% agarose gel and stained with ethidium bromide, 
visualized, and documented under ultraviolet (Alpha Imager instru-
ment). Sequences for primers used are given in Table 1.
Statistical analysis
All the data were expressed as mean ± SEM. Data were analyzed by 
an unpaired t-test using GraphPad Prism demo version 5 for Win-
dows (GraphPad Software, San Diego, CA, USA).
Results
In vitro staining
ORO staining clearly indicated the accumulation of fat as 
small droplets in a well-distributed manner throughout 
the cells. With increasing doses of oleic acid and butter, 
a progressive increase in the steatosis was observed 
(Figure  1). The butter-induced steatosis was comparable 
to that obtained with oleic acid and, hence, can be con-
sidered as a suitable substance to be used to induce a cell 
culture steatosis/NAFLD model.
In vitro quantification
The extent of fat accumulation within the cells was deter-
mined after quantifying the red color added to the cell 
by the ORO dye. The increase in absorbance reflected 
the increase in degree of steatosis. As the concentra-
tion of oleic acid increased from 0.25 mM to 4 mM, there 
was a marked increase in absorbance, which reflected 
the increased fatty accumulation within the Chang liver 
cells (Figure 1). In the case of the butter-treated group, a 
linear increase in fat accumulation within the Chang liver 
cells was observed as the log concentration of butter was 
increased from 10 − 9 to 1 (Figure 1).
In vivo studies
Correlation between fat-rich diet and weight gain
Both special diet-treated mice and controls gained 4–5 g 
of weight. Though more significant weight gain and feed 
consumption was expected from the special diet, a lesser 
weight gain was observed. This insignificant difference 
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in weight gain between the two groups could be due to 
the starting age of the animals, i.e. the animals were 
2 months old at the time of the start of the experiment. 
Hence, all the animals had already reached nearly 30 g 
of weight resulting in insignificant weight gain (Figure 2). 
Further, as the special diet was not forced fed, test mice, 
due to the high fat content of the special diet, could have 
consumed proportionately less than its normal feeding 
habit on control diet. Hence, though the control group 
consumed nearly 7 g per animal per day, the special diet 
group animals consumed only around 3 g per animal per 
day. Moreover, the diet was introduced only in limited 
quantities of 40–80 g per visit to prevent spoilage and 
encourage feeding in mice.
In vivo biochemical parameters
Alanine aminotransferase (ALT), total and direct biliru-
bin levels in the special diet group were found to be sig-
nificantly elevated (p < 0.05) compared to the control diet 
group after the 10th week onward. Alkaline phosphatase 
(ALP) level in the special diet group showed significant 
(p < 0.05) elevation from 5th week onward compared to the 
control group. Aspartate aminotransferase (AST) triglycer-
ides were found to be significantly (p < 0.05) elevated on 
the 15th week. However, the level of direct bilirubin was 
more pronounced in the special group than in the control. 
Increased levels of these parameters are indicative of liver 
disease (Figure 3).
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Figure 1: Oleic acid- and butter-induced steatosis in Chang liver cells.
As the oleic acid and butter concentrations increased, there was an increase in triglyceride accumulation, seen as red patches in the cell. As 
the concentration of oleic acid increased from 0.25 mM to 4 mM and the concentration of butter increased from 10 − 9 to 1, a marked increase 
in the amount and extent of fat (stained red, with oil red O) accumulation was observed.
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PTEN and miR-21 expression
Gene expression studies showed that PTEN is downregu-
lated in the special diet group compared to that in the control 
group. This indicates that the special diet used in this model 
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Figure 2: Body weight of animals.
Changes in the body weight of mice fed with normal and special diet 
over a period of 15 weeks.
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Figure 3: Biochemical estimation.
All the values are mean ± SEM of six animals. Data are analyzed using the t-test where *p < 0.05 compared to controls.
is able to induce NAFLD and steatosis. After 10 weeks, the 
gene expression studies showed faint bands not consistent 
with any proposed theories. This was equal in both groups.
The third time period again showed a marginal but 
evident indication that PTEN was still downregulated 
compared to the control group. However, in the case of 
miR-21, the levels of miR-21 expression were almost similar 
in both groups (Figure 4).
In vivo histopathology
Histopathology evaluation of hepatocytes showed clump-
ing, loss of shape and perivenular necrotic changes. 
Inflammatory changes, viz., hepatic ballooning and 
cytoplasmic aggregates were observed in the 15th week 
 histology. This clearly indicates that the high-fat diet had 
initiated progression to NAFLD (Figure 5).
Discussion
Metabolic syndrome affecting liver has not received 
the same attention as is given to the other metabolic 
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syndromes, viz., diabetes and coronary heart disease. 
However, considering the growing incidence of NAFLD 
leading to hepatocellular carcinoma (HCC) there is an 
urgent need to develop treatment strategies, but this 
could be achieved only if suitable in vitro and in vivo 
animal models are created, which can replicate the condi-
tions of NAFLD observed in the human population [4]. In 
the present study, the NAFLD was developed in cell lines 
and in mice using edible butter. Butter is one of the major 
ingredients present in fat-rich diets and is consumed 
throughout the world. It contains a mixture of fatty acids, 
viz., saturated and unsaturated fatty acids. The saturated 
fatty acid present in butter is generally converted to oleic 
acid. This oleic acid along with other long chain unsatu-
rated fatty acids present in the butter could cause hepatic 
steatosis [15]. In the present study, the edible butter-
induced steatosis in the cell line was compared with oleic 
acid-induced steatosis [10]. This kind of model will serve 
as a better indicator to study the progression of the disease 
and ultimately testing of newer treatment strategies.
For establishing, the butter-induced steatosis in 
in vitro, the concentration of butter was an important 
parameter. The concentration of butter used for the study 
was expressed as a log of its quantity, as it contains a 
number of components, which is difficult to quantify. 
Pure butter was given a value of 10. Concentrations made 
subsequently from this would, therefore, represent 10 − 1, 
10 − 2, etc. The steatosis induced by oleic acid and butter 
in Chang liver cells was assessed using ORO, a diazo dye, 
which stains neutral triglycerides and lipids. The accu-
mulation of fatty acid within liver cells was seen as small 
red oil droplets distributed throughout the cells. The 
extent of steatosis induced in the cells depended on the 
dose of oleic acid and butter. After a certain concentration 
range, i.e. 0.5 and 1.75 mM for oleic acid and 10 − 4 to 10 − 8 
for butter, it showed the plateau phase for fatty accumu-
lation, which might be due to the plateau phase of apop-
tosis as reported by Cui et al. [10] (Figures 3 and 5). Such 
a quantitative model can be useful in studying and cor-
relating the effects of inflammatory mediators, apoptosis 
and stress with NAFLD. Even any other inducible factor of 
NAFLD can be identified and correlated to events within 
the quantifiable concentration range of that inducing 
agent.
In in vivo study, mice were fed with butter-rich special 
diet for 15 weeks. A diet rich in butter not only contains 
palmitic acid and oleic acid but also a mixture of various 
forms of fatty acids, which mimics the diet pattern of 
humans [11]. Studies showed that weight gain in the mice 
was only 4–5 g in both special groups as well as control diet 
groups. This might be because the animals were obtained 
at 2 months of age and had already reached nearly 30 g 
of weight. Furthermore, as the special diet was not forced 
fed, we can see that weight gain in the special diet group 
did not exceed that of the control diet. The other possi-
ble reasons might be due to the high fat content of the 
diet, which affected the feed intake. Though the control 
diet was consumed at nearly 7 g per animal per day, the 
PTEN expression miR-21 expression
S1
1 2 3 4 1 2 3 4
5 Weeks/
35 days
10 Weeks/
70 days
15 Weeks/
105 days
S2 C1 C2 S1 S2 C1 C2
S2 S3 C2 C3S2 S3 C2 C3
S4 S5 C4 C5S4 S5 C4 C5
Figure 4: Expression of PTEN and miR-21.
While the test groups that were fed with special diet (S1 and S2) showed increased PTEN expression, there was no difference in the level of 
miR-21 expression compared to the control groups (C1 and C2) fed with normal diet.
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special diet was only at around 3 g per animal, but the 
weight changes in the groups were the same.
Steatohepatitis develops as a result of a “double hit”. 
The presence of oxidizable fat within the liver leads to the 
development of steatosis, which is considered as the “first 
hit”. The “first hit” is mainly due to excess fat accumula-
tion and insulin resistance, which further increases the 
availability of free fatty acid. The free fatty acid is oxidized 
to aldehyde, viz., 4-hydroxynoneal and malondialdehyde 
(MDA), which are the main contributing factors for the 
development of Mallory bodies. Besides, these aldehydes 
activate NF-κB, which are involved in the recruitment of 
various inflammatory cytokines and generating free radi-
cals. These free radicals are considered as the “second 
hit”. Along with free radicals, decreased hepatic ATP turn-
over causes oxidative stress in the liver and finally leads 
to steatohepatitis [9, 16]. In such steatohepatic conditions, 
lipogenic tissues such as the liver, which are involved in 
maintaining lipid homeostasis, are mostly affected due 
to free fatty acid-mediated downregulation of PTEN and 
may lead to hepatocellular carcinoma. Previously in vitro 
experiments to study the effect of unsaturated fatty acids 
on hepatic cells have been carried out on HepG2 and 
HuH-7 cells [1]. PTEN is an anti-proliferative gene, which 
suppresses proliferation of hepatic carcinoma cells by 
suppressing the action of PI3K through dephospho-
rylation [17]. PTEN belongs to the protein tyrosine phos-
phatase families that are expressed constitutively in the 
cell. Downregulation of PTEN often leads to increased 
cell proliferation and invasion. PTEN is inactivated in the 
presence of reactive oxygen species such as hydrogen per-
oxide due to the formation of disulfide linkages between 
the cysteine residues at its active site. Type I phospho-
inositide 3-kinases (PI 3) are activated upon phospho-
rylation. These kinases regulate the number of cellular 
activities including cell survival, growth, proliferation, 
Control diet 5 week
Control diet 10 week
Control diet 15 week
Special diet 5 week
Special diet 10 week
Special diet 15 week
Figure 5: Histopathology of liver from normal- and special diet-fed mice.
The figure shows the effects of the special diet on the liver hepatocytes such as necro-inflammatory changes, hepatocytes ballooning.
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and motility in response to insulin. PTEN antagonizes PI 
3-kinases through its phosphatase action and regulates its 
activities [18]. After this, disorder further detoriates to HCC 
either through cirrhosis or directly without involving cir-
rhosis. Excess unsaturated free fatty acids suppress PTEN 
expression. The present study showed a similar trend in 
the downregulation of PTEN.
miR, which comprises a group of small nucleotides 
(19–25 in length), is involved in negative regulation of 
genes and plays an important role in HCC through direct 
suppression of PTEN expression. Subtype, miR-21 acts 
mainly by activating focal adhesion kinase (FAK) and 
Akt through phosphorylation, while PTEN acts by involv-
ing dephosphorylation of FAK in controlling cell migra-
tion. Thus, upregulation of miR-21  will directly indicate 
an increased malignancy condition [19]. However, in the 
current study, there was no significant difference in the 
miR-21 level between the control and test groups, which 
might be due to the short duration of the study. The study 
was not continued until the development of HCC, which 
might be the reason for the unchanged level of miR-21. 
In addition, the other cofactor such as diabetes was not 
induced. However, it is important to ascertain that as 
 miR-21 levels have been proposed to increase in the NAFLD 
pathology, the ratio between miR-21 and PTEN levels will 
also increase, which is more important than their quanti-
tative increase. Hence, a fall in PTEN levels alone would 
clearly disturb the balance, and miR-21 will be greater rela-
tive to the amount of PTEN present. Thus, the observed 
downregulation of PTEN and unchanged miR21 indicates 
that NAFLD progression was started.
Normally, in the NAFLD, the degree of inflamma-
tion and fibrosis are confirmed by liver biopsy. Typically 
macro vascular steatosis, lobular inflammation, hepato-
cytes necrosis, Mallory bodies, fibrosis, and cirrhosis are 
observed in NAFLD histology [20]. In the present study, 
the histology and biochemical parameters were consid-
ered as an essential factor for the assessment of the end-
points of a special high-fat diet. These tests confirmed that 
special diets had initiated progression to NAFLD. Excess 
lipids were stored as large vesicles displacing the nucleus 
resulting in a signet ring appearance. These lipids were 
reported to be triglycerides, a neutral lipid by Donato et al. 
2007 [15]. This macro vesicular steatosis is an important 
hallmark of NAFLD, which occurs due to the increased 
influx but reduced efflux of free fatty acid. It is observed 
in obesity and diabetes-induced steatosis. Steatosis due to 
drug toxin or genetic condition results in impaired β-fatty 
acid oxidation and results in microvesicular hepatic stea-
tosis with no nuclear displacement of the nucleus [21]. We 
could not find the symptom of NASH as the dietary intake 
of mice were under their control. Even earlier reports sug-
gested that when rats were fed with a fat-rich diet both 
in liquid and solid forms, only those rats fed with high-
fat liquid diet progressed to NASH even though both the 
groups developed steatosis [22].
The biochemical estimations in serum samples 
showed a significant elevation of LFT parameters, i.e. 
AST, ALT, ALP direct and total bilirubin levels in the but-
ter-rich diet groups. Elevation in these parameters was 
a clear indication of liver disease. An increase in triglyc-
eride levels reflected an increase in imbalance in lipid 
metabolism, which was supported by a histopathology 
study. Thus, after analyzing the biochemical parameters, 
histopathological markers, and expression study, it can be 
concluded that NAFLD was induced by a butter-rich diet. 
Prolonged treatment and adding some more hits may lead 
to NASH.
However, studying NAFLD on a short duration model 
in mice would not be completely justifiable considering 
that the duration of the disease progression in normal 
patients often takes years. Considering the short lifespan 
of the rodents, it would be better to consider inducing 
more stress factors than a high-fat diet alone to induce 
“hits” that would trigger a faster progression of disease in 
the liver.
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